Vaccines against meningococcal diseases

M Pizza, R Bekkat-Berkani, R Rappuoli - Microorganisms, 2020 - mdpi.com
Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening
conditions. Thanks to advancements in vaccine development, vaccines are now available …

Complement and bacterial infections: from molecular mechanisms to therapeutic applications

DAC Heesterbeek, ML Angelier, RA Harrison… - Journal of innate …, 2018 - karger.com
Complement is a complex protein network of plasma, and an integral part of the innate
immune system. Complement activation results in the rapid clearance of bacteria by immune …

Vaccination of infants with meningococcal group B vaccine (4CMenB) in England

SN Ladhani, N Andrews, SR Parikh… - … England Journal of …, 2020 - Mass Medical Soc
Abstract Background In September 2015, the United Kingdom introduced the
multicomponent meningococcal group B vaccine (4CMenB, Bexsero) into its publicly funded …

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect

Y Ruiz García, WY Sohn, KL Seib, MK Taha… - npj Vaccines, 2021 - nature.com
Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical
manifestations, but the bacteria share up to 80–90% genome sequence identity. The …

Potential application of exosomes in vaccine development and delivery

MN Huda, M Nurunnabi - Pharmaceutical Research, 2022 - Springer
Exosomes are cell-derived components composed of proteins, lipid, genetic information,
cytokines, and growth factors. They play a vital role in immune modulation, cell-cell …

Synthetic Pseudaminic-Acid-Based Antibacterial Vaccine Confers Effective Protection against Acinetobacter baumannii Infection

R Wei, X Yang, H Liu, T Wei, S Chen, X Li - ACS central science, 2021 - ACS Publications
Acinetobacter baumannii exhibits resistance to most first-line antibiotics; thus, development
of new antibacterial agents is urgently required. Pseudaminic acid exists as the surface …

Improving vaccines against Streptococcus pneumoniae using synthetic glycans

P Kaplonek, N Khan, K Reppe… - Proceedings of the …, 2018 - National Acad Sciences
Streptococcus pneumoniae remains a deadly disease in small children and the elderly even
though conjugate and polysaccharide vaccines based on isolated capsular polysaccharides …

How vaccines work: immune effector mechanisms and designer vaccines

S Sell - Expert review of vaccines, 2019 - Taylor & Francis
Introduction: Three major advances have led to increase in length and quality of human life:
increased food production, improved sanitation and induction of specific adaptive immune …

The Main Etiological Factors, Methods of Prevention and Treatment of Meningitis

AS Taxirovich - International Journal of Scientific Trends, 2023 - scientifictrends.org
Signs and symptoms of meningeal inflammation have been recorded in countless ancient
texts throughout history; however, the term'meningitis' came into general usage after …

Protecting group principles suited to late stage functionalization and global deprotection in oligosaccharide synthesis

D Dhara, A Dhara, PV Murphy, LA Mulard - Carbohydrate research, 2022 - Elsevier
Chemical synthesis is a powerful tool to access homogeneous complex glycans, which
relies on protecting group (PG) chemistry. However, the overall efficiency of chemical glycan …